 | • レポートコード：MRC23Q38348 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（2-3日） • 産業分類：医療機器 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の定量神経筋伝達モニター市場について調査・分析し、世界の定量神経筋伝達モニター市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（シングル単収縮刺激神経筋伝達モニター、ダブルバースト刺激神経筋伝達モニター）、用途別セグメント分析（病院、外傷センター、外来手術センター）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、GE Healthcare、Dragerwerk、CAREstream Medical、RGB Medical Devices、Organon Laboratories、IDMED、Mercury Medicalなどが含まれています。世界の定量神経筋伝達モニター市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、定量神経筋伝達モニター市場規模を推定する際に考慮しました。本レポートは、定量神経筋伝達モニターの世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、定量神経筋伝達モニターに関するビジネス上の意思決定に役立てることを目的としています。 ・定量神経筋伝達モニター市場の概要 - 製品の定義 - 定量神経筋伝達モニターのタイプ別セグメント - 世界の定量神経筋伝達モニター市場規模：タイプ別分析（シングル単収縮刺激神経筋伝達モニター、ダブルバースト刺激神経筋伝達モニター） - 定量神経筋伝達モニターの用途別セグメント - 世界の定量神経筋伝達モニター市場規模：用途別分析（病院、外傷センター、外来手術センター） - 世界の定量神経筋伝達モニター市場規模予測（2018年-2029年） - 定量神経筋伝達モニターの平均価格推移（2018年-2029年） - 前提条件と制限事項 ・メーカー別競争状況 - メーカー別市場シェア - 世界の主要メーカー、業界ランキング分析 - メーカー別平均価格 - 定量神経筋伝達モニター市場の競争状況およびトレンド ・定量神経筋伝達モニターの地域別市場規模 - 北米の定量神経筋伝達モニター市場規模（2018年-2029年） - アメリカの定量神経筋伝達モニター市場規模（2018年-2029年） - ヨーロッパの定量神経筋伝達モニター市場規模（2018年-2029年） - アジア太平洋の定量神経筋伝達モニター市場規模（2018年-2029年） - 中国の定量神経筋伝達モニター市場規模（2018年-2029年） - 日本の定量神経筋伝達モニター市場規模（2018年-2029年） - 韓国の定量神経筋伝達モニター市場規模（2018年-2029年） - インドの定量神経筋伝達モニター市場規模（2018年-2029年） - オーストラリアの定量神経筋伝達モニター市場規模（2018年-2029年） - 中南米の定量神経筋伝達モニター市場規模（2018年-2029年） - 中東・アフリカの定量神経筋伝達モニター市場規模（2018年-2029年） ・タイプ別セグメント：シングル単収縮刺激神経筋伝達モニター、ダブルバースト刺激神経筋伝達モニター - 世界の定量神経筋伝達モニターのタイプ別販売量（2018年-2023年） - 世界の定量神経筋伝達モニターのタイプ別売上（2018年-2023年） - 世界の定量神経筋伝達モニターのタイプ別価格 ・用途別セグメント：病院、外傷センター、外来手術センター - 世界の定量神経筋伝達モニターの用途別販売量（2018年-2023年） - 世界の定量神経筋伝達モニターの用途別売上（2018年-2023年） - 世界の定量神経筋伝達モニターの用途別価格 ・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向 GE Healthcare、Dragerwerk、CAREstream Medical、RGB Medical Devices、Organon Laboratories、IDMED、Mercury Medical ・産業チェーンと販売チャネルの分析 - 定量神経筋伝達モニター産業チェーン分析 - 定量神経筋伝達モニターの主要原材料 - 定量神経筋伝達モニターの販売チャネル - 定量神経筋伝達モニターのディストリビューター - 定量神経筋伝達モニターの主要顧客 ・定量神経筋伝達モニター市場ダイナミクス - 定量神経筋伝達モニターの業界動向 - 定量神経筋伝達モニター市場の成長ドライバ、課題、阻害要因 ・調査成果および結論 ・調査方法とデータソース |
Highlights
The global Quantitative Neuromuscular Transmission Monitor market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Quantitative Neuromuscular Transmission Monitor is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Quantitative Neuromuscular Transmission Monitor is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Quantitative Neuromuscular Transmission Monitor include GE Healthcare, Dragerwerk, CAREstream Medical, RGB Medical Devices, Organon Laboratories, IDMED and Mercury Medical, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Quantitative Neuromuscular Transmission Monitor, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Quantitative Neuromuscular Transmission Monitor.
The Quantitative Neuromuscular Transmission Monitor market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Quantitative Neuromuscular Transmission Monitor market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Quantitative Neuromuscular Transmission Monitor manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
GE Healthcare
Dragerwerk
CAREstream Medical
RGB Medical Devices
Organon Laboratories
IDMED
Mercury Medical
Segment by Type
Single Twitch Stimulation Neuromuscular Transmission Monitor
Double Burst Stimulation Neuromuscular Transmission Monitor
Segment by Application
Hospital
Trauma Centers
Ambulatory Surgical Centers
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Quantitative Neuromuscular Transmission Monitor manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Quantitative Neuromuscular Transmission Monitor in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Quantitative Neuromuscular Transmission Monitor Market Overview
1.1 Product Overview and Scope of Quantitative Neuromuscular Transmission Monitor
1.2 Quantitative Neuromuscular Transmission Monitor Segment by Type
1.2.1 Global Quantitative Neuromuscular Transmission Monitor Market Value Comparison by Type (2023-2029)
1.2.2 Single Twitch Stimulation Neuromuscular Transmission Monitor
1.2.3 Double Burst Stimulation Neuromuscular Transmission Monitor
1.3 Quantitative Neuromuscular Transmission Monitor Segment by Application
1.3.1 Global Quantitative Neuromuscular Transmission Monitor Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Trauma Centers
1.3.4 Ambulatory Surgical Centers
1.4 Global Quantitative Neuromuscular Transmission Monitor Market Size Estimates and Forecasts
1.4.1 Global Quantitative Neuromuscular Transmission Monitor Revenue 2018-2029
1.4.2 Global Quantitative Neuromuscular Transmission Monitor Sales 2018-2029
1.4.3 Global Quantitative Neuromuscular Transmission Monitor Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Quantitative Neuromuscular Transmission Monitor Market Competition by Manufacturers
2.1 Global Quantitative Neuromuscular Transmission Monitor Sales Market Share by Manufacturers (2018-2023)
2.2 Global Quantitative Neuromuscular Transmission Monitor Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Quantitative Neuromuscular Transmission Monitor Average Price by Manufacturers (2018-2023)
2.4 Global Quantitative Neuromuscular Transmission Monitor Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Quantitative Neuromuscular Transmission Monitor, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Quantitative Neuromuscular Transmission Monitor, Product Type & Application
2.7 Quantitative Neuromuscular Transmission Monitor Market Competitive Situation and Trends
2.7.1 Quantitative Neuromuscular Transmission Monitor Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Quantitative Neuromuscular Transmission Monitor Players Market Share by Revenue
2.7.3 Global Quantitative Neuromuscular Transmission Monitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Quantitative Neuromuscular Transmission Monitor Retrospective Market Scenario by Region
3.1 Global Quantitative Neuromuscular Transmission Monitor Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Quantitative Neuromuscular Transmission Monitor Global Quantitative Neuromuscular Transmission Monitor Sales by Region: 2018-2029
3.2.1 Global Quantitative Neuromuscular Transmission Monitor Sales by Region: 2018-2023
3.2.2 Global Quantitative Neuromuscular Transmission Monitor Sales by Region: 2024-2029
3.3 Global Quantitative Neuromuscular Transmission Monitor Global Quantitative Neuromuscular Transmission Monitor Revenue by Region: 2018-2029
3.3.1 Global Quantitative Neuromuscular Transmission Monitor Revenue by Region: 2018-2023
3.3.2 Global Quantitative Neuromuscular Transmission Monitor Revenue by Region: 2024-2029
3.4 North America Quantitative Neuromuscular Transmission Monitor Market Facts & Figures by Country
3.4.1 North America Quantitative Neuromuscular Transmission Monitor Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Quantitative Neuromuscular Transmission Monitor Sales by Country (2018-2029)
3.4.3 North America Quantitative Neuromuscular Transmission Monitor Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Quantitative Neuromuscular Transmission Monitor Market Facts & Figures by Country
3.5.1 Europe Quantitative Neuromuscular Transmission Monitor Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Quantitative Neuromuscular Transmission Monitor Sales by Country (2018-2029)
3.5.3 Europe Quantitative Neuromuscular Transmission Monitor Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Quantitative Neuromuscular Transmission Monitor Market Facts & Figures by Country
3.6.1 Asia Pacific Quantitative Neuromuscular Transmission Monitor Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Quantitative Neuromuscular Transmission Monitor Sales by Country (2018-2029)
3.6.3 Asia Pacific Quantitative Neuromuscular Transmission Monitor Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Quantitative Neuromuscular Transmission Monitor Market Facts & Figures by Country
3.7.1 Latin America Quantitative Neuromuscular Transmission Monitor Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Quantitative Neuromuscular Transmission Monitor Sales by Country (2018-2029)
3.7.3 Latin America Quantitative Neuromuscular Transmission Monitor Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Quantitative Neuromuscular Transmission Monitor Market Facts & Figures by Country
3.8.1 Middle East and Africa Quantitative Neuromuscular Transmission Monitor Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Quantitative Neuromuscular Transmission Monitor Sales by Country (2018-2029)
3.8.3 Middle East and Africa Quantitative Neuromuscular Transmission Monitor Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Quantitative Neuromuscular Transmission Monitor Sales by Type (2018-2029)
4.1.1 Global Quantitative Neuromuscular Transmission Monitor Sales by Type (2018-2023)
4.1.2 Global Quantitative Neuromuscular Transmission Monitor Sales by Type (2024-2029)
4.1.3 Global Quantitative Neuromuscular Transmission Monitor Sales Market Share by Type (2018-2029)
4.2 Global Quantitative Neuromuscular Transmission Monitor Revenue by Type (2018-2029)
4.2.1 Global Quantitative Neuromuscular Transmission Monitor Revenue by Type (2018-2023)
4.2.2 Global Quantitative Neuromuscular Transmission Monitor Revenue by Type (2024-2029)
4.2.3 Global Quantitative Neuromuscular Transmission Monitor Revenue Market Share by Type (2018-2029)
4.3 Global Quantitative Neuromuscular Transmission Monitor Price by Type (2018-2029)
5 Segment by Application
5.1 Global Quantitative Neuromuscular Transmission Monitor Sales by Application (2018-2029)
5.1.1 Global Quantitative Neuromuscular Transmission Monitor Sales by Application (2018-2023)
5.1.2 Global Quantitative Neuromuscular Transmission Monitor Sales by Application (2024-2029)
5.1.3 Global Quantitative Neuromuscular Transmission Monitor Sales Market Share by Application (2018-2029)
5.2 Global Quantitative Neuromuscular Transmission Monitor Revenue by Application (2018-2029)
5.2.1 Global Quantitative Neuromuscular Transmission Monitor Revenue by Application (2018-2023)
5.2.2 Global Quantitative Neuromuscular Transmission Monitor Revenue by Application (2024-2029)
5.2.3 Global Quantitative Neuromuscular Transmission Monitor Revenue Market Share by Application (2018-2029)
5.3 Global Quantitative Neuromuscular Transmission Monitor Price by Application (2018-2029)
6 Key Companies Profiled
6.1 GE Healthcare
6.1.1 GE Healthcare Corporation Information
6.1.2 GE Healthcare Description and Business Overview
6.1.3 GE Healthcare Quantitative Neuromuscular Transmission Monitor Sales, Revenue and Gross Margin (2018-2023)
6.1.4 GE Healthcare Quantitative Neuromuscular Transmission Monitor Product Portfolio
6.1.5 GE Healthcare Recent Developments/Updates
6.2 Dragerwerk
6.2.1 Dragerwerk Corporation Information
6.2.2 Dragerwerk Description and Business Overview
6.2.3 Dragerwerk Quantitative Neuromuscular Transmission Monitor Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Dragerwerk Quantitative Neuromuscular Transmission Monitor Product Portfolio
6.2.5 Dragerwerk Recent Developments/Updates
6.3 CAREstream Medical
6.3.1 CAREstream Medical Corporation Information
6.3.2 CAREstream Medical Description and Business Overview
6.3.3 CAREstream Medical Quantitative Neuromuscular Transmission Monitor Sales, Revenue and Gross Margin (2018-2023)
6.3.4 CAREstream Medical Quantitative Neuromuscular Transmission Monitor Product Portfolio
6.3.5 CAREstream Medical Recent Developments/Updates
6.4 RGB Medical Devices
6.4.1 RGB Medical Devices Corporation Information
6.4.2 RGB Medical Devices Description and Business Overview
6.4.3 RGB Medical Devices Quantitative Neuromuscular Transmission Monitor Sales, Revenue and Gross Margin (2018-2023)
6.4.4 RGB Medical Devices Quantitative Neuromuscular Transmission Monitor Product Portfolio
6.4.5 RGB Medical Devices Recent Developments/Updates
6.5 Organon Laboratories
6.5.1 Organon Laboratories Corporation Information
6.5.2 Organon Laboratories Description and Business Overview
6.5.3 Organon Laboratories Quantitative Neuromuscular Transmission Monitor Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Organon Laboratories Quantitative Neuromuscular Transmission Monitor Product Portfolio
6.5.5 Organon Laboratories Recent Developments/Updates
6.6 IDMED
6.6.1 IDMED Corporation Information
6.6.2 IDMED Description and Business Overview
6.6.3 IDMED Quantitative Neuromuscular Transmission Monitor Sales, Revenue and Gross Margin (2018-2023)
6.6.4 IDMED Quantitative Neuromuscular Transmission Monitor Product Portfolio
6.6.5 IDMED Recent Developments/Updates
6.7 Mercury Medical
6.6.1 Mercury Medical Corporation Information
6.6.2 Mercury Medical Description and Business Overview
6.6.3 Mercury Medical Quantitative Neuromuscular Transmission Monitor Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Mercury Medical Quantitative Neuromuscular Transmission Monitor Product Portfolio
6.7.5 Mercury Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Quantitative Neuromuscular Transmission Monitor Industry Chain Analysis
7.2 Quantitative Neuromuscular Transmission Monitor Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Quantitative Neuromuscular Transmission Monitor Production Mode & Process
7.4 Quantitative Neuromuscular Transmission Monitor Sales and Marketing
7.4.1 Quantitative Neuromuscular Transmission Monitor Sales Channels
7.4.2 Quantitative Neuromuscular Transmission Monitor Distributors
7.5 Quantitative Neuromuscular Transmission Monitor Customers
8 Quantitative Neuromuscular Transmission Monitor Market Dynamics
8.1 Quantitative Neuromuscular Transmission Monitor Industry Trends
8.2 Quantitative Neuromuscular Transmission Monitor Market Drivers
8.3 Quantitative Neuromuscular Transmission Monitor Market Challenges
8.4 Quantitative Neuromuscular Transmission Monitor Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer